ICON PLC (ICLR) Stock Fundamental Analysis

NASDAQ:ICLR • IE0005711209

108.335 USD
+0.06 (+0.06%)
Last: Mar 3, 2026, 03:07 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, ICLR scores 5 out of 10 in our fundamental rating. ICLR was compared to 57 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ICLR get a neutral evaluation. Nothing too spectacular is happening here. ICLR scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, ICLR could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year ICLR was profitable.
  • ICLR had a positive operating cash flow in the past year.
  • In the past 5 years ICLR has always been profitable.
  • ICLR had a positive operating cash flow in each of the past 5 years.
ICLR Yearly Net Income VS EBIT VS OCF VS FCFICLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • The Return On Assets of ICLR (3.63%) is better than 77.19% of its industry peers.
  • With a decent Return On Equity value of 6.42%, ICLR is doing good in the industry, outperforming 77.19% of the companies in the same industry.
  • ICLR's Return On Invested Capital of 6.74% is fine compared to the rest of the industry. ICLR outperforms 78.95% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ICLR is significantly below the industry average of 11.60%.
  • The 3 year average ROIC (5.80%) for ICLR is below the current ROIC(6.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROIC 6.74%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ICLR Yearly ROA, ROE, ROICICLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • ICLR has a better Profit Margin (7.40%) than 77.19% of its industry peers.
  • In the last couple of years the Profit Margin of ICLR has declined.
  • ICLR has a Operating Margin of 13.99%. This is in the better half of the industry: ICLR outperforms 75.44% of its industry peers.
  • In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
  • ICLR's Gross Margin of 28.15% is on the low side compared to the rest of the industry. ICLR is outperformed by 77.19% of its industry peers.
  • ICLR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
ICLR Yearly Profit, Operating, Gross MarginsICLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICLR is destroying value.
  • The number of shares outstanding for ICLR has been reduced compared to 1 year ago.
  • The number of shares outstanding for ICLR has been increased compared to 5 years ago.
  • Compared to 1 year ago, ICLR has an improved debt to assets ratio.
ICLR Yearly Shares OutstandingICLR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICLR Yearly Total Debt VS Total AssetsICLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.62, we must say that ICLR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.62, ICLR is in line with its industry, outperforming 54.39% of the companies in the same industry.
  • ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
  • ICLR's Debt to FCF ratio of 3.53 is amongst the best of the industry. ICLR outperforms 80.70% of its industry peers.
  • ICLR has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • ICLR's Debt to Equity ratio of 0.31 is in line compared to the rest of the industry. ICLR outperforms 49.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Altman-Z 1.62
ROIC/WACC0.76
WACC8.84%
ICLR Yearly LT Debt VS Equity VS FCFICLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
  • The Current ratio of ICLR (1.06) is worse than 82.46% of its industry peers.
  • ICLR has a Quick Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ICLR (1.06) is worse than 75.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
ICLR Yearly Current Assets VS Current LiabilitesICLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for ICLR have decreased by -5.99% in the last year.
  • ICLR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.23% yearly.
  • Looking at the last year, ICLR shows a decrease in Revenue. The Revenue has decreased by -2.46% in the last year.
  • Measured over the past years, ICLR shows a very strong growth in Revenue. The Revenue has been growing by 24.17% on average per year.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%

3.2 Future

  • ICLR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.14% yearly.
  • ICLR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.48% yearly.
EPS Next Y-5.37%
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
EPS Next 5Y2.14%
Revenue Next Year-2.67%
Revenue Next 2Y-1.68%
Revenue Next 3Y0.22%
Revenue Next 5Y1.48%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICLR Yearly Revenue VS EstimatesICLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ICLR Yearly EPS VS EstimatesICLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.21 indicates a reasonable valuation of ICLR.
  • Based on the Price/Earnings ratio, ICLR is valued cheaply inside the industry as 98.25% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.13. ICLR is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 8.43, which indicates a very decent valuation of ICLR.
  • Based on the Price/Forward Earnings ratio, ICLR is valued cheaply inside the industry as 98.25% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.11, ICLR is valued rather cheaply.
Industry RankSector Rank
PE 8.21
Fwd PE 8.43
ICLR Price Earnings VS Forward Price EarningsICLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ICLR is valued cheaper than 98.25% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ICLR is valued cheaper than 98.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.58
EV/EBITDA 7.36
ICLR Per share dataICLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The decent profitability rating of ICLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.54
EPS Next 2Y-4.18%
EPS Next 3Y0.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ICLR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICON PLC

NASDAQ:ICLR (3/3/2026, 3:07:03 PM)

108.335

+0.06 (+0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22
Earnings (Next)04-30
Inst Owners105.53%
Inst Owner Change4.32%
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap8.27B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts74.17
Price Target159.5 (47.23%)
Short Float %2.65%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)-23.67%
PT rev (3m)-23.97%
EPS NQ rev (1m)-2.15%
EPS NQ rev (3m)-2.29%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)-0.49%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 8.21
Fwd PE 8.43
P/S 1.02
P/FCF 8.58
P/OCF 7.25
P/B 0.89
P/tB N/A
EV/EBITDA 7.36
EPS(TTM)13.19
EY12.18%
EPS(NY)12.85
Fwd EY11.86%
FCF(TTM)12.63
FCFY11.66%
OCF(TTM)14.93
OCFY13.79%
SpS106.11
BVpS122.25
TBVpS-38.98
PEG (NY)N/A
PEG (5Y)0.54
Graham Number190.47
Profitability
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROCE 8.53%
ROIC 6.74%
ROICexc 6.98%
ROICexgc 176.34%
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
FCFM 11.9%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Debt/EBITDA 1.89
Cap/Depr 45.31%
Cap/Sales 2.17%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 160.84%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 1.62
F-Score6
WACC8.84%
ROIC/WACC0.76
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-5.37%
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
EPS Next 5Y2.14%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.67%
Revenue Next 2Y-1.68%
Revenue Next 3Y0.22%
Revenue Next 5Y1.48%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year0.44%
EBIT Next 3Y0.52%
EBIT Next 5Y2.03%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%

ICON PLC / ICLR FAQ

Can you provide the ChartMill fundamental rating for ICON PLC?

ChartMill assigns a fundamental rating of 5 / 10 to ICLR.


What is the valuation status for ICLR stock?

ChartMill assigns a valuation rating of 7 / 10 to ICON PLC (ICLR). This can be considered as Undervalued.


How profitable is ICON PLC (ICLR) stock?

ICON PLC (ICLR) has a profitability rating of 6 / 10.


What is the valuation of ICON PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ICON PLC (ICLR) is 8.21 and the Price/Book (PB) ratio is 0.89.


How financially healthy is ICON PLC?

The financial health rating of ICON PLC (ICLR) is 5 / 10.